Literature DB >> 17526736

Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis.

Ran Xiao1, Ye Sun, Jian-Hua Ding, Shengrong Lin, Dave W Rose, Michael G Rosenfeld, Xiang-Dong Fu, Xue Li.   

Abstract

The members of the SR family of splicing regulators were initially characterized for their critical roles in constitutive and regulated splicing. They are implicated in different aspects of gene expression processes, including transcription, RNA stability, mRNA transport, and translational control. While knockout studies have demonstrated their essential functions during animal development, the pathway(s) leading to a specific cellular phenotype remains poorly understood. We report here that the SR protein SC35 controls cell proliferation during pituitary gland development but is completely dispensable in terminal differentiated mature cardiomyocytes in mice. We show that loss of SC35 in mouse embryonic fibroblasts induces G2/M cell cycle arrest and genomic instability, resulting at least in part from p53 hyperphosphorylation and hyperacetylation. While p53 hyperphosphorylation appears related to ATM activation, its hyperacetylation has been attributed to the increased expression of the acetyltransferase gene p300 and the aberrant splicing of the deacetylase gene SirT1. These findings reveal the involvement of SC35 in specific pathways in regulating cell proliferation and genomic stability during mammalian organogenesis and suggest its potential function in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526736      PMCID: PMC1952092          DOI: 10.1128/MCB.00288-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

Review 1.  Pre-mRNA splicing and human disease.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

2.  Structure of a Sir2 enzyme bound to an acetylated p53 peptide.

Authors:  Jose L Avalos; Ivana Celic; Shabazz Muhammad; Michael S Cosgrove; Jef D Boeke; Cynthia Wolberger
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

3.  Splicing oncogenes.

Authors:  Anchang Hu; Xiang-Dong Fu
Journal:  Nat Struct Mol Biol       Date:  2007-03       Impact factor: 15.369

4.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

Review 5.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

6.  Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.

Authors:  Hwei-Ling Cheng; Raul Mostoslavsky; Shin'ichi Saito; John P Manis; Yansong Gu; Parin Patel; Roderick Bronson; Ettore Appella; Frederick W Alt; Katrin F Chua
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

7.  Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.

Authors:  Jian-Hua Ding; Xiangdong Xu; Dongmei Yang; Pao-Hsien Chu; Nancy D Dalton; Zhen Ye; Joanne M Yeakley; Heping Cheng; Rui-Ping Xiao; John Ross; Ju Chen; Xiang-Dong Fu
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

8.  Expression of splicing factors in human ovarian cancer.

Authors:  D-C Fischer; Kathleen Noack; Ingo B Runnebaum; Dirk O Watermann; Dirk G Kieback; Stefan Stamm; Elmar Stickeler
Journal:  Oncol Rep       Date:  2004-05       Impact factor: 3.906

9.  Nuclear export and retention signals in the RS domain of SR proteins.

Authors:  Demian Cazalla; Jun Zhu; Lisa Manche; Elisabeth Huber; Adrian R Krainer; Javier F Cáceres
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Tissue-specific regulation of retinal and pituitary precursor cell proliferation.

Authors:  Xue Li; Valentina Perissi; Forrest Liu; David W Rose; Michael G Rosenfeld
Journal:  Science       Date:  2002-07-18       Impact factor: 47.728

View more
  88 in total

1.  A single ancient origin for prototypical serine/arginine-rich splicing factors.

Authors:  Sophie Califice; Denis Baurain; Marc Hanikenne; Patrick Motte
Journal:  Plant Physiol       Date:  2011-12-12       Impact factor: 8.340

2.  The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome.

Authors:  Eun Joo Song; Shannon L Werner; Jakob Neubauer; Frank Stegmeier; Julie Aspden; Donald Rio; J Wade Harper; Stephen J Elledge; Marc W Kirschner; Michael Rape
Journal:  Genes Dev       Date:  2010-07-01       Impact factor: 11.361

3.  SON is a spliceosome-associated factor required for mitotic progression.

Authors:  Michael S Y Huen; Shirley M H Sy; Ka Man Leung; Yick-Pang Ching; George L Tipoe; Cornelia Man; Shuo Dong; Junjie Chen
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 4.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

5.  Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones.

Authors:  Xiang-Yang Zhong; Jian-Hua Ding; Joseph A Adams; Gourisankar Ghosh; Xiang-Dong Fu
Journal:  Genes Dev       Date:  2009-02-15       Impact factor: 11.361

6.  The emerging role of splicing factors in cancer.

Authors:  Ana Rita Grosso; Sandra Martins; Maria Carmo-Fonseca
Journal:  EMBO Rep       Date:  2008-10-10       Impact factor: 8.807

7.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.

Authors:  Liang Chen; Jia-Yu Chen; Yi-Jou Huang; Ying Gu; Jinsong Qiu; Hao Qian; Changwei Shao; Xuan Zhang; Jing Hu; Hairi Li; Shunmin He; Yu Zhou; Omar Abdel-Wahab; Dong-Er Zhang; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2018-01-27       Impact factor: 17.970

8.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells.

Authors:  Yu Lu; Yuin-Han Loh; Hu Li; Marcella Cesana; Scott B Ficarro; Jignesh R Parikh; Nathan Salomonis; Cheng-Xu Delon Toh; Stelios T Andreadis; C John Luckey; James J Collins; George Q Daley; Jarrod A Marto
Journal:  Cell Stem Cell       Date:  2014-05-08       Impact factor: 24.633

Review 9.  Splicing factor gene mutations in hematologic malignancies.

Authors:  Borja Saez; Matthew J Walter; Timothy A Graubert
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

Review 10.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.